Ferensin

Medicinal product

(Invented) name

Ferensin

Active substance (s)

Kasos milteliai (Proteazė/Lipazė/Amilazė)

Strength

240 mg (400 V/10000 V/7500 V)

Pharmaceutical form

skrandyje neirios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A09AA02, Multienzymes (lipase, protease etc.)

Marketing authorisation holder

UAB Eletis Pharma, Lietuva

Date of authorisation

2018-05-24

Date of renewal

2023-03-22

Documents

4222 Ferensin RPP 2024 06 25.docx

Pancreas powder IBE_viesas_AR.pdf

4222 Pakuotės lapelis 2024 06 25.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Kasos milteliai (Proteazė/Lipazė/Amilazė)	240 mg (400 V/10000 V/7500 V)

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99489	85596	1085596	lizdinė plokštelė	N10		Nereceptinis	LT/1/18/4222/001	Tiekiama	-	-	No	-	-
99490	85597	1085597	lizdinė plokštelė	N20		Nereceptinis	LT/1/18/4222/002	Netiekiama	-	-	No	-	-
99491	85598	1085598	lizdinė plokštelė	N50		Nereceptinis	LT/1/18/4222/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-03-22	Perregistruotas
2018-05-24	Registruotas